Literature DB >> 1200701

Lymphocyte stimulation in the cellular inflammatory reaction of some human skin tumours.

H Pullmann, G K Steigleder.   

Abstract

By labelling dermal infiltrate cells with H3-thymidine, two types of skin tumours can be distinguished: one type with many labelled cells in the infiltrate (H3-thymidine labelling index, H3-I), the other with few labelled cells. Type I includes malignant melanoma (H3-I = 2.2%) and hemangioendothelioma (2.8%). Type II includes metastases of malignant melanoma (1%), squamous cell carcinoma (1.1%), basel cell epithelioma (0.5%), nevus cell nevus (0.6%), and nevoid lentigo (0.4). The number of labelled cells in the cellular reaction of Type II tumours does not differ significantly from that in normal human corium (0.75%), though there may be a dense cellular reaction. DNA-synthesizing cells were classified with the aid of characteristical stainings and histochemical methods. A vast majority of them were found to be lymphocytes. Our research underlines the special importance of cellular inflammatory reaction, i.e. cellular immunity, im malignant melanoma and probably in hemangioendothelioma.

Entities:  

Mesh:

Year:  1975        PMID: 1200701     DOI: 10.1007/bf00561147

Source DB:  PubMed          Journal:  Arch Dermatol Res            Impact factor:   3.017


  25 in total

1.  The histochemical demonstration of leucine aminopeptidase.

Authors:  M M NACHLAS; D T CRAWFORD; A M SELIGMAN
Journal:  J Histochem Cytochem       Date:  1957-05       Impact factor: 2.479

2.  Immune phagocytosis in vivo of human malignant melanoma cells.

Authors:  T H The; R Eibergen; H B Lamberts; J Oldhoff; H Schraffordt Koops; H O Nieweg
Journal:  Acta Med Scand       Date:  1972 Jul-Aug

3.  Correlation of immune reactivity and clinical status in cancer.

Authors:  P B Chretien; W J Catalona; P L Twomey; W F Sample
Journal:  Ann Clin Lab Sci       Date:  1974 Sep-Oct       Impact factor: 1.256

4.  [Proliferative activity of cellular infiltrates in psoriasis].

Authors:  J M Lachapelle; M De la Brassinne
Journal:  Arch Belg Dermatol Syphiligr       Date:  1972 Jul-Sep

5.  Cell-mediated immunity in patients with malignant melanoma.

Authors:  R M Mackie; W G Spilg; C E Thomas; A J Cochran
Journal:  Br J Dermatol       Date:  1972-12       Impact factor: 9.302

6.  Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.

Authors:  A Z Bluming; C L Vogel; J L Ziegler; J W Kiryabwire
Journal:  J Natl Cancer Inst       Date:  1972-01       Impact factor: 13.506

7.  [An in vitro method for the autoradiographic determination of the cell kinetics of erythroblasts in animals and humans].

Authors:  H O Klein; K J Lennartz; M Eder; R Gross
Journal:  Histochemie       Date:  1970

8.  [Kinetics of cell proliferation in normal epidermis before and after application of 1 per cent vitamin A-acid solution (author's transl)].

Authors:  H Pullmann; K J Lennartz; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1975-08-29       Impact factor: 3.017

Review 9.  Immunological factors which influence response to immunotherapy in malignant melanoma.

Authors:  D Morton; F R Eilber; R A Malmgren; W C Wood
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

10.  [Significance of histological findings in the prognosis of malignant melanoma. Findings in 253 melanoma patients followed for 5 years].

Authors:  H Gartmann; H Tritsch
Journal:  Dtsch Med Wochenschr       Date:  1972-06-02       Impact factor: 0.628

View more
  1 in total

1.  [Cytokinetics of epidermal and dermal cells in allergic contact dermatitis and atopic dermatitis (author's transl)].

Authors:  R Brunner; H Pullmann; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1976-06-21       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.